Keywords: pfizer, third-quarter, net, income, rises, w-l, merger
Pfizer's third-quarter net income rises 30% as W-L merger brings in savings
Article | 24 October 2000
Pfizer has announced third-quarter 2000 revenues of $7.21 billion, anincrease of 7% over the like, year-earlier period, while net income rose 30% to $1.71 billion ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
